ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Thomas B. Rezentes, Mark A. Prelas, Eric Lukosi, Matthew L. Watermann, Jack Crawford, and Richard H. Olsher
Nuclear Technology | Volume 187 | Number 1 | July 2014 | Pages 96-102
Technical Note | Radiation Transport and Protection | doi.org/10.13182/NT11-105
Articles are hosted by Taylor and Francis Online.
A computer-based investigative technique, using the Los Alamos Monte Carlo code MCNP5 version 1.51 (Radiation Safety Information Computational Center), was completed to assess the shallow dose equivalent (SDE) reported on the Landauer, Inc.,TM Luxel+ optically stimulated light (OSL) dosimeter. Experimental test irradiations were conducted on 18 OSL dosimeters through various controlled exposures to the source (10 mCi 90Sr). The reported SDE for each test irradiation was compared to the results for SDE calculated using MCNP5. All test irradiation experiments were conducted with the 90Sr source placed in direct contact with the dosimeter with slight placement changes across the dosimeter face. It was found that these slight adjustments caused vast differences in reported doses by Landauer. The SDE determined in a tissue matrix using MCNP5 was studied for two of the dosimeter badge geometries, and it was found that some qualitative agreement exists between the reported and simulated doses in contradiction with the experimental results. Further simulated analysis was not conducted because precise source-dosimeter geometries and the algorithm used by Landauer to analyze its Luxel+ OSL dosimeters were not known. These results indicate that a future study should be conducted with more rigorous simulated benchmarking to verify these results.